615 related articles for article (PubMed ID: 26149984)
1. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
[TBL] [Abstract][Full Text] [Related]
2. Plasmodium falciparum and Plasmodium vivax Demonstrate Contrasting Chloroquine Resistance Reversal Phenotypes.
Wirjanata G; Handayuni I; Prayoga P; Leonardo L; Apriyanti D; Trianty L; Wandosa R; Gobay B; Kenangalem E; Poespoprodjo JR; Noviyanti R; Kyle DE; Cheng Q; Price RN; Marfurt J
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533239
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.
Aguiar AC; Pereira DB; Amaral NS; De Marco L; Krettli AU
Malar J; 2014 Feb; 13():73. PubMed ID: 24581308
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
6. Comparative ex vivo activity of novel endoperoxides in multidrug-resistant plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Wirjanata G; Sebayang B; Piera KA; Wittlin S; Haynes RK; Möhrle JJ; Anstey NM; Kenangalem E; Price RN
Antimicrob Agents Chemother; 2012 Oct; 56(10):5258-63. PubMed ID: 22850522
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax.
Price RN; Marfurt J; Chalfein F; Kenangalem E; Piera KA; Tjitra E; Anstey NM; Russell B
Antimicrob Agents Chemother; 2010 Dec; 54(12):5146-50. PubMed ID: 20876370
[TBL] [Abstract][Full Text] [Related]
8. Determinants of in vitro drug susceptibility testing of Plasmodium vivax.
Russell B; Chalfein F; Prasetyorini B; Kenangalem E; Piera K; Suwanarusk R; Brockman A; Prayoga P; Sugiarto P; Cheng Q; Tjitra E; Anstey NM; Price RN
Antimicrob Agents Chemother; 2008 Mar; 52(3):1040-5. PubMed ID: 18180357
[TBL] [Abstract][Full Text] [Related]
9. Potent Ex Vivo Activity of Naphthoquine and Methylene Blue against Drug-Resistant Clinical Isolates of Plasmodium falciparum and Plasmodium vivax.
Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Trianty L; Kenangalem E; Noviyanti R; Campo B; Poespoprodjo JR; Möhrle JJ; Price RN; Marfurt J
Antimicrob Agents Chemother; 2015 Oct; 59(10):6117-24. PubMed ID: 26195523
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Machunter B; Tjitra E; Anstey NM; Price RN
Antimicrob Agents Chemother; 2011 Sep; 55(9):4461-4. PubMed ID: 21730116
[TBL] [Abstract][Full Text] [Related]
11. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
[TBL] [Abstract][Full Text] [Related]
12. Novel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro.
Sáenz FE; Mutka T; Udenze K; Oduola AM; Kyle DE
Antimicrob Agents Chemother; 2012 Sep; 56(9):4685-92. PubMed ID: 22710117
[TBL] [Abstract][Full Text] [Related]
13. Expression of Plasmodium vivax crt-o Is Related to Parasite Stage but Not Ex Vivo Chloroquine Susceptibility.
Pava Z; Handayuni I; Wirjanata G; To S; Trianty L; Noviyanti R; Poespoprodjo JR; Auburn S; Price RN; Marfurt J
Antimicrob Agents Chemother; 2016 Jan; 60(1):361-7. PubMed ID: 26525783
[TBL] [Abstract][Full Text] [Related]
14. Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.
Chaorattanakawee S; Lon C; Chann S; Thay KH; Kong N; You Y; Sundrakes S; Thamnurak C; Chattrakarn S; Praditpol C; Yingyuen K; Wojnarski M; Huy R; Spring MD; Walsh DS; Patel JC; Lin J; Juliano JJ; Lanteri CA; Saunders DL
Malar J; 2017 Sep; 16(1):392. PubMed ID: 28964258
[TBL] [Abstract][Full Text] [Related]
15. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J; Müeller I; Sie A; Maku P; Goroti M; Reeder JC; Beck HP; Genton B
Am J Trop Med Hyg; 2007 Nov; 77(5):947-54. PubMed ID: 17984359
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium vivax trophozoites insensitive to chloroquine.
Sharrock WW; Suwanarusk R; Lek-Uthai U; Edstein MD; Kosaisavee V; Travers T; Jaidee A; Sriprawat K; Price RN; Nosten F; Russell B
Malar J; 2008 May; 7():94. PubMed ID: 18505560
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the chloroquine sensitivity of Plasmodium vivax from Calcutta and Orissa, India.
Nandy A; Addy M; Maji AK; Bandyopadhyay AK
Ann Trop Med Parasitol; 2003 Apr; 97(3):215-20. PubMed ID: 12803853
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.
Marfurt J; Chalfein F; Prayoga P; Wabiser F; Kenangalem E; Piera KA; Fairlie DP; Tjitra E; Anstey NM; Andrews KT; Price RN
Antimicrob Agents Chemother; 2011 Mar; 55(3):961-6. PubMed ID: 21135175
[TBL] [Abstract][Full Text] [Related]
19. Reversal of Chloroquine Resistance of Plasmodium vivax in Aotus Monkeys.
Obaldia N; Milhous WK; Kyle DE
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941642
[TBL] [Abstract][Full Text] [Related]
20. In vitro chloroquine resistance for Plasmodium vivax isolates from the Western Brazilian Amazon.
Chehuan YF; Costa MR; Costa JS; Alecrim MG; Nogueira F; Silveira H; Brasil LW; Melo GC; Monteiro WM; Lacerda MV
Malar J; 2013 Jul; 12():226. PubMed ID: 23819884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]